Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica

Rheumatology (Oxford). 2024 Jan 4;63(1):158-164. doi: 10.1093/rheumatology/kead189.

Abstract

Objective: The main objective of this study was to analyse the prevalence and characteristics of subclinical GCA in patients with PMR.

Methods: This was a cross-sectional multicentre international study of consecutive patients with newly diagnosed PMR without symptoms or signs suggestive of GCA. All patients underwent US of the temporal superficial, common carotid, subclavian and axillary arteries. Patients with halo signs in at least one examined artery were considered to have subclinical GCA. The clinical, demographic and laboratory characteristics of the PMR group without subclinical vasculitis were compared with subclinical GCA, and the pattern of vessel involvement was compared with that of a classical single-centre GCA cohort.

Results: We included 346 PMR patients, 267 (77.2%) without subclinical GCA and 79 (22.8%) with subclinical GCA. The PMR patients with subclinical GCA were significantly older, had a longer duration of morning stiffness and more frequently reported hip pain than PMR without subclinical GCA. PMR with subclinical GCA showed a predominant extracranial large vessel pattern of vasculitic involvement compared with classical GCA, where the cranial phenotype predominated. The patients with PMR in the classical GCA group showed a pattern of vessel involvement similar to classical GCA without PMR but different from PMR with subclinical involvement.

Conclusion: More than a fifth of the pure PMR patients had US findings consistent with subclinical GCA. This specific subset of patients showed a predilection for extracranial artery involvement. The optimal screening strategy to assess the presence of vasculitis in PMR remains to be determined.

Keywords: GCA; PMR; epidemiology; ultrasonography; vasculitis.

MeSH terms

  • Cross-Sectional Studies
  • Giant Cell Arteritis* / diagnosis
  • Giant Cell Arteritis* / epidemiology
  • Humans
  • Pain
  • Polymyalgia Rheumatica* / diagnosis
  • Polymyalgia Rheumatica* / epidemiology
  • Prevalence